Hakenbeck R, Ellerbrok H, Briese T, Handwerger S, Tomasz A
Antimicrob Agents Chemother. 1986 Oct;30(4):553-8. doi: 10.1128/AAC.30.4.553.
There are several major differences between the penicillin-binding proteins (PBPs) of highly penicillin-resistant and -susceptible strains of pneumococci. The highest-molecular-size PBP 1a (98 kilodaltons [kDa]) of susceptible pneumococci is not detectable in resistant bacteria. Instead, resistant strains contain a PBP of smaller size: 92 and 94 kDa in South African strains 8249 and A95210, respectively, and 96 kDa in New Guinea strain 2955 (S. Zighelboim and A. Tomasz, Antimicrob. Agents Chemother. 17:434-442, 1980). Using antibodies prepared against PBP 1a of penicillin-susceptible pneumococci, we demonstrated that these anomalous-sized proteins in the resistant strains are immunologically related to PBP 1a of penicillin-susceptible bacteria. A second difference between the PBP patterns of strain 8249 and the susceptible pneumococci is that the 78-kDa PBP 2b is not detectable by the radioactive penicillin binding assay in the resistant strain. Using antibodies prepared against PBP 2b of susceptible cells, we demonstrated the presence of PBP 2b in membrane preparations from strain 8249 cells. Thus, the poor detection of this PBP appears to be related to its greatly decreased affinity for the antibiotic molecule. We also compared the patterns of penicillin-labeled peptides derived from PBPs of resistant and susceptible cells during partial proteolysis by V8 protease. Several changes were observable in small peptides carrying the beta-lactam binding site generated from the high Mr (PBP 1a-related) binding proteins. In contrast, no differences in the pattern of penicillin-labeled peptides were seen when the pattern of PBP 2a of susceptible pneumococci was compared with the peptide pattern of PBP 2a from resistant strains. One of the resistant isolates (strain 2955) also had a PBP 3 with a higher-than-normal molecular weight. This protein gave strong positive reaction with antibodies against PBP 3 of susceptible cells. Examination of the pattern of penicilloyl peptides generated from the susceptible and resistant PBP 3s during partial proteolysis revealed only differences which seem to reside distant from the beta-lactam binding site.
青霉素高度耐药和敏感的肺炎球菌菌株的青霉素结合蛋白(PBPs)之间存在几个主要差异。敏感肺炎球菌中分子量最大的PBP 1a(98千道尔顿[kDa])在耐药细菌中无法检测到。相反,耐药菌株含有较小尺寸的PBP:南非菌株8249和A95210中分别为92 kDa和94 kDa,新几内亚菌株2955中为96 kDa(S. Zighelboim和A. Tomasz,《抗菌剂与化疗》17:434 - 442,1980年)。使用针对青霉素敏感肺炎球菌的PBP 1a制备的抗体,我们证明耐药菌株中这些异常大小的蛋白质在免疫上与青霉素敏感细菌的PBP 1a相关。菌株8249和敏感肺炎球菌的PBP模式的第二个差异是,通过放射性青霉素结合试验在耐药菌株中无法检测到78 kDa的PBP 2b。使用针对敏感细胞的PBP 2b制备的抗体,我们证明了菌株8249细胞的膜制剂中存在PBP 2b。因此,这种PBP检测不佳似乎与其对抗生素分子的亲和力大大降低有关。我们还比较了在V8蛋白酶部分蛋白水解过程中,耐药和敏感细胞的PBPs衍生的青霉素标记肽的模式。在由高Mr(与PBP 1a相关)结合蛋白产生的携带β-内酰胺结合位点的小肽中可观察到几个变化。相比之下,当将敏感肺炎球菌的PBP 2a模式与耐药菌株的PBP 2a肽模式进行比较时,青霉素标记肽的模式没有差异。其中一个耐药分离株(菌株2955)还具有分子量高于正常的PBP 3。该蛋白与针对敏感细胞的PBP 3的抗体产生强烈阳性反应。在部分蛋白水解过程中,对敏感和耐药PBP 3产生的青霉素酰肽模式的检查仅发现了似乎位于远离β-内酰胺结合位点的差异。